Therefore, the question to which extent TSPO might contribute to one phenotype or another and, accordingly, to the pro-inflammatory/anti-tumor or anti-inflammatory/pro-tumor responses cannot be answered yet. The gene discussed is TSPO; the disease is neoplasm.